NYSE · BRK-B
Berkshire Hathaway Inc.
$541.96+$1.62 (+0.3%)
Berkshire Hathaway Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.45% below the high.
Loading market information…
NASDAQ · CRVL · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
CorVel Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.48% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
CorVel Corporation’s next earnings report is currently expected on Nov 3, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow CorVel Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs. Their service portfolio includes a wide array of network solutions, featuring automated medical fee auditing, management and reimbursement for preferred providers, retrospective utilization reviews, and detailed scrutiny of both facility and professional claims. Additionally, they offer pharmacy services, directed care programs, Medicare solutions, clearinghouse functionalities, independent medical examinations, and inpatient medical bill reviews. Beyond network services, CorVel provides a suite of patient management offerings, encompassing claims and case management, round-the-clock nurse triage, utilization management, vocational rehabilitation, and life care planning. The company also processes property and casualty claims specifically for self-insured clients. Established in 1987, CorVel maintains its corporate headquarters in Fort Worth, Texas.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:47 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$541.96+$1.62 (+0.3%)
Berkshire Hathaway Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.45% below the high.
$343.58+$4.28 (+1.26%)
JPMorgan Chase & Co.’s quoted price sits in the upper half of its reported 52-week range, 6.25% below the high.
$410.54+$9.94 (+2.48%)
Visa Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.98% below the high.
$635.70+$25.39 (+4.16%)
Mastercard Incorporated’s quoted price sits in the upper half of its reported 52-week range, 0.91% below the high.
$51.14+$0.29 (+0.57%)
Bank of America Corporation’s quoted price sits in the lower half of its reported 52-week range, 21.6% below the high.
$101.36+$0.02 (+0.02%)
HealthEquity, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.82% below the high.
$4.25-$0.08 (-1.85%)
Evolent Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 40.14% below the high.
$24.00+$1.00 (+4.35%)
Claritev Corporation’s quoted price sits in the lower half of its reported 52-week range, 67.43% below the high.
